GlobeNewswire Inc | Jan 20, 2021 06:03PM EST

January 20, 2021

WILMINGTON, Del., Jan. 20, 2021 (GLOBE NEWSWIRE) -- Rigrodsky Law, P.A. announces that it is investigating Oxford Immunotec Global PLC (Oxford Immunotec) (NASDAQ GS: OXFD) regarding possible breaches of fiduciary duties and other violations of law related to Oxford Immunotecs agreement to be acquired by PerkinElmer, Inc. (PerkinElmer) (NYSE: PKI). Under the terms of the agreement, Oxford Immunotecs shareholders will receive $22.00 in cash per share.

To learn more about this investigation and your rights, visit: https://www.rl-legal.com/cases-oxford-immunotec-global-plc.

You may also contact Seth D. Rigrodsky or Gina M. Serra cost and obligation free at (888) 969-4242 or info@rl-legal.com.

Rigrodsky Law, P.A., with offices in Delaware and New York, has recovered hundreds of millions of dollars on behalf of investors and achieved substantial corporate governance reforms in securities fraud and corporate class actions nationwide.

Attorney advertising. Prior results do not guarantee a similar outcome.

CONTACT:

Rigrodsky Law, P.A.Seth D. RigrodskyGina M. Serra(888) 969-4242 (Toll Free)(302) 295-5310Fax: (302) 654-7530info@rl-legal.com https://rl-legal.com